Thymic epithelial tumor-Associated Cytopenia: A 10-year observational study in France

Journal of Thoracic Oncology

Volumn 11, Issue 3, 2016, Pages 391-399

  Rivoisy, Claire ^a   Besse, Benjamin ^b   Girard, Nicolas ^c   Lioger, Bertrand ^d   Viallard, Jean Francois ^e   Lega, Jean Christophe ^f,g   Rullier, Patricia ^h   Perlat, Antoinette ⁱ   Lerouge, Delphine ^j   Clement Duchene, Christelle ^k,l   Ebbo, Mikael ^m   Bosseray, Annick ⁿ   Godeau, Bertrand ^o   Lambotte, Olivier ^a,p,q,r  

^a BICÊTRE HOSPITAL   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

^c LOUIS PRADEL HOSPITAL   (France)

^d University Hospitals of Tours   (France)

^e UNIVERSITÉ DE BORDEAUX   (France)

^f LABORATOIRE DE BIOMÉTRIE ET BIOLOGIE EVOLUTIVE   (France)

^g UNIVERSITÉ LYON 1   (France)

^h MONTPELLIER UNIVERSITY HOSPITAL   (France)

ⁱ Department of Cardiology   (France)

^j University Medical Center Caen   (France)

^k University Medical Center of Nancy   (France)

^l UNIVERSITÉ DE LORRAINE   (France)

^m AIX MARSEILLE UNIVERSITY   (France)

ⁿ UNIV GRENOBLE ALPES   (France)

^o Paris Est University   (France)

^p UNIVERSITÉ PARIS SACLAY   (France)

^q DIF   (France)

^r INSERM   (France)

more..

Author keywords

Good syndrome; Infectious complications; Pure red cell aplasia; Thymic epithelial tumor

Indexed keywords

ALEMTUZUMAB; AMOXICILLIN; ATOVAQUONE; AZATHIOPRINE; AZITHROMYCIN; CORTICOSTEROID; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DANAZOL; ELTROMBOPAG; GRANULOCYTE COLONY STIMULATING FACTOR; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; LYMPHOCYTE ANTIBODY; MYCOPHENOLATE MOFETIL; PENTAMIDINE; RITUXIMAB; STEROID;

ADD ON THERAPY; ADULT; AGED; AGRANULOCYTOSIS; ANTIBIOTIC PROPHYLAXIS; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE HEMOLYTIC ANEMIA; BACTERIAL INFECTION; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CYTOMEGALOVIRUS INFECTION; CYTOPENIA; FEMALE; FOLLOW UP; FRANCE; GOOD SYNDROME; HERPES ZOSTER; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INVASIVE ASPERGILLOSIS; MALE; METASTASIS; MUCOCUTANEOUS CANDIDIASIS; MULTICENTER STUDY; NEUTROPENIA; OBSERVATIONAL STUDY; OPPORTUNISTIC INFECTION; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; PURE RED CELL ANEMIA; RELAPSE; RETROSPECTIVE STUDY; THROMBOCYTOPENIA; THYMIC EPITHELIAL TUMOR; THYMIC EPITHELIAL TUMOR ASSOCIATED CYTOPENIA; THYMOMA; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR REGRESSION; BLOOD; CLINICAL TRIAL; MIDDLE AGED; NEOPLASM; PATHOLOGY;

AGED; FRANCE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS, GLANDULAR AND EPITHELIAL; RETROSPECTIVE STUDIES; THROMBOCYTOPENIA; THYMUS NEOPLASMS;

EID: 84962574871     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1016/j.jtho.2015.11.012     Document Type: Article

References (20)

1. Ruffini E, Venuta F. Management of thymic tumors: A European perspective. J Thorac Dis. 2014; 6(suppl 2): S228-S237.
2. Degos L, Faille A, Housset M, et al. Syndrome of neutrophil agranulocytosis, hypogammaglobulinemia, and thymoma. Blood. 1982; 60: 968-972.
3. Dessypris EN, Lipton JM. Red cell aplasia. In: Greer JP, Foerster J, Lukens JN, Rodgers GM, Paraskevas F, Glader B, eds. Wintrobes Clinical Hematology. Philadelphia, PA: Linpiccott Williams and Wilkins; 2004: 142-147.
4. Hirokawa M, Sawada K, Fujishima N, et al. Long-Term response and outcome following immunosuppressive therapy in thymoma-Associated pure red cell aplasia: A nationwide cohort study in Japan by the PRCA collaborative study group. Haematologica. 2008; 93: 27-33.
5. Qin J, Liu L. Thymoma with idiopathic thrombocytopenic purpura: report of a case. J Thorac Cardiovasc Surg. 2005; 129: 453.
6. Jethava Y, Alamelu J, Rangarajan S, et al. Acquired agranulocytosis and factor XI deficiency in association with thymoma. J Clin Oncol. 2011; 29: e604-e606.
7. De Keyzer K, Peeters P, Verhelst C, et al. Autoimmune haemolytic anaemia associated with a thymoma: case report and review of the literature. Acta Clin Belg. 2009; 64: 447-451.
8. Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009; 45: 228-247.
9. Lechner K, Jäger U. How I treat autoimmune hemolytic anemias in adults. Blood. 2010; 116: 1831-1838.
10. Rodeghiero F, Stasi R, Gernsheimer T, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood. 2009; 113: 2386-2393.
11. Roumier M, Loustau V, Guillaud C, et al. Characteristics and outcome of warm autoimmune hemolytic anemia in adults: New insights based on a single-center experience with 60 patients. Am J Hematol. 2014; 89: E150-E155.
12. Haddy TB, Rana SR, Castro O. Benign ethnic neutropenia: what is a normal absolute neutrophil count? J Lab Clin Med. 1999; 133: 15-22.
13. Al-Herz W, Bousfiha A, Casanova J-L, et al. Primary immunodeficiency diseases: An update on the classification from the International Union Of Immunological Societies Expert Committee for Primary Immunodeficiency. Front Immunol. 2014; 5: 162.
14. Tarr PE, Sneller MC, Mechanic LJ, et al. Infections in patients with immunodeficiency with thymoma (Good syndrome). Report of 5 cases and review of the literature. Medicine (Baltimore). 2001; 80: 123-133.
15. Holbro A, Jauch A, Lardinois D, et al. High prevalence of infections and autoimmunity in patients with thymoma. Hum Immunol. 2012; 73: 287-290.
16. Kelesidis T, Yang O. Goods syndrome remains a mystery after 55 years: A systematic review of the scientific evidence. Clin Immunol. 2010; 135: 347-363.
17. Marx A, Ströbel P, Badve SS, et al. ITMIG consensus statement on the use of the WHO histological classification of thymoma and thymic carcinoma: refined definitions, histological criteria, and reporting. J Thorac Oncol. 2014; 9: 596-611.
18. Hermaszewski RA, Webster AD. Primary hypogammaglobulinaemia: A survey of clinical manifestations and complications. Q J Med. 1993; 86: 31-42.
19. Malphettes M, Gérard L, Galicier L, et al. Good Syndrome: An adult-onset immunodeficiency remarkable for its high incidence of invasive infections and autoimmune complications. Clin Infect Dis. 2015; 61: e13-e19.
20. Hirokawa M, Sawada K, Fujishima N, et al. Long-Term outcome of patients with acquired chronic pure red cell aplasia (PRCA) following immunosuppressive therapy: A final report of the nationwide cohort study in 2004/2006 by the Japan PRCA Collaborative Study Group. Br J Haematol. 2015; 169: 879-886.